A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
Q2
A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
Q3
A 58-year-old man with end-stage pulmonary fibrosis is being evaluated for lung transplantation. His current static compliance is 25 mL/cm H2O (normal: 200 mL/cm H2O). He also has mild obesity (BMI 32) and ankylosing spondylitis affecting chest wall mobility. Post-transplant, assuming successful bilateral lung transplant with normal donor lungs, what would be the expected change in his total respiratory system compliance?
Q4
A research study compares two patients with different lung pathologies but identical functional residual capacity (FRC) of 3.0 L. Patient A has pulmonary fibrosis with FRC above the steep portion of the compliance curve. Patient B has emphysema with FRC on the flat upper portion of the curve. Both attempt to inhale the same tidal volume. Analyzing their work of breathing, which statement best characterizes the difference?
Q5
A 32-year-old woman develops acute respiratory distress syndrome (ARDS) following sepsis. She is mechanically ventilated with tidal volume 450 mL and plateau pressure 35 cm H2O (PEEP 10 cm H2O). Her static compliance is calculated as 18 mL/cm H2O. The team considers changing ventilator settings. Analyzing her respiratory mechanics, what change would most effectively improve compliance while minimizing ventilator-induced lung injury?
Q6
A 55-year-old woman with idiopathic pulmonary fibrosis and a 40-year-old man with severe emphysema both have the same total lung capacity of 4.5 L on pulmonary function testing. However, their pressure-volume curves show opposite patterns. During inspiration from FRC, which patient requires greater change in pleural pressure to achieve the same tidal volume, and why?
Q7
A 70-year-old man with severe kyphoscoliosis presents with chronic dyspnea. Pulmonary function testing shows reduced total lung capacity and functional residual capacity. His lung tissue biopsy is normal, but respiratory muscle strength testing shows normal values. Analysis of his pressure-volume curve shows a normal curve for lung tissue alone, but decreased total respiratory system compliance. What explains his respiratory mechanics?
Q8
A premature infant born at 28 weeks gestation develops respiratory distress syndrome. Arterial blood gas shows pH 7.25, PaCO2 55 mmHg, PaO2 50 mmHg on 60% FiO2. Chest X-ray reveals ground-glass opacities. Surfactant therapy is administered. Which mechanism best explains the improvement in lung mechanics following treatment?
Q9
A 45-year-old woman presents with progressive dyspnea and dry cough over 6 months. Chest CT shows bilateral interstitial infiltrates. Pulmonary function tests reveal FEV1/FVC ratio of 0.85, reduced total lung capacity, and a steep pressure-volume curve shifted downward and to the right. What is the primary mechanical change in her lungs?
Q10
A 65-year-old man with COPD undergoes pulmonary function testing. His FEV1 is 65% predicted, and spirometry shows an obstructive pattern. A pressure-volume loop demonstrates reduced elastic recoil with increased total lung capacity. When comparing his lungs to a healthy individual, what physiological change best explains his altered compliance?
Respiratory System Indian Medical PG Practice Questions and MCQs
Question 1: A 68-year-old man with both severe COPD (emphysema) and newly diagnosed idiopathic pulmonary fibrosis presents with worsening dyspnea. His pressure-volume curve shows a complex pattern with features of both diseases. Static compliance measured at mid-lung volumes is 120 mL/cm H2O. His pulmonologist must decide on optimal management. Synthesizing the pathophysiology of both conditions, what represents the most significant clinical challenge in managing his combined disease?
A. The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity (Correct Answer)
B. Emphysema treatment with bronchodilators will worsen fibrosis progression
C. Pulmonary rehabilitation cannot address the opposing mechanical derangements
D. The increased compliance from emphysema completely negates decreased compliance from fibrosis
E. Oxygen therapy beneficial for COPD will accelerate fibrotic changes
Explanation: ***The opposing effects on compliance create a pseudonormal total respiratory compliance masking disease severity***
- In **Combined Pulmonary Fibrosis and Emphysema (CPFE)**, the high compliance of **emphysema** (loss of elastic recoil) and low compliance of **fibrosis** (increased stiffness) mathematically offset each other.
- This leads to **pseudonormalization** of lung volumes (like FVC or TLC) and static compliance, which can dangerously mask the physiologic severity and lead to delayed clinical intervention.
*Emphysema treatment with bronchodilators will worsen fibrosis progression*
- **Bronchodilators** target airway smooth muscle tone and do not have a known mechanistic pathway to accelerate **collagen deposition** or fibroblast activation in the interstitium.
- Standard therapy for the **obstructive component** of COPD is generally safe to use in patients who also have concurrent interstitial lung disease.
*Pulmonary rehabilitation cannot address the opposing mechanical derangements*
- While **pulmonary rehabilitation** cannot physically reverse the mechanical changes in the lung tissue, it is highly effective at improving **skeletal muscle efficiency** and dyspnea perception.
- It remains a cornerstone of management for both **restrictive and obstructive** diseases by optimizing the patient's functional capacity despite lung damage.
*The increased compliance from emphysema completely negates decreased compliance from fibrosis*
- While the mechanics are opposing, they rarely "completely negate" one another; rather, they result in severe **gas exchange impairment** (profoundly low DLCO) out of proportion to the spirometry.
- High-resolution CT usually shows distinct regional differences, typically **upper-lobe emphysema** and **lower-lobe fibrosis**, rather than a uniform mechanical cancellation.
*Oxygen therapy beneficial for COPD will accelerate fibrotic changes*
- Standard **supplemental oxygen** used to maintain target saturations does not trigger or accelerate the **pathogenesis of idiopathic pulmonary fibrosis**.
- Oxygen is essential for managing **pulmonary hypertension**, which is a frequent and severe complication in patients with the combined CPFE phenotype.
Question 2: A 42-year-old woman with systemic sclerosis develops both pulmonary fibrosis and chest wall restriction from skin thickening. Her measured total respiratory system compliance is 30 mL/cm H2O. Testing with complete paralysis and positive pressure ventilation shows isolated lung compliance of 50 mL/cm H2O. She is being considered for immunosuppressive therapy versus supportive care. Evaluate which intervention would provide the greatest improvement in her respiratory mechanics.
A. Aggressive immunosuppression targeting both lung and skin disease
B. Lung-directed therapy only, as it contributes more to total compliance reduction
C. Supportive care only, as both components contribute equally and irreversibly
D. Combined therapy targeting lung disease with chest wall mobilization (Correct Answer)
E. Chest wall-directed physical therapy, as it is the primary limiting factor
Explanation: ***Combined therapy targeting lung disease with chest wall mobilization***
- Total respiratory compliance (30 mL/cm H₂O) is determined by the formula **1/C_total = 1/C_lung + 1/C_chest wall**; calculating this yields a **chest wall compliance (C_cw)** of 75 mL/cm H₂O.
- Since both **C_lung (50 mL/cm H₂O)** and **C_cw (75 mL/cm H₂O)** are significantly lower than the normal value of ~200 mL/cm H₂O, addressing both the **interstitial lung disease** and the **extrapulmonary restriction** is necessary.
*Aggressive immunosuppression targeting both lung and skin disease*
- While immunosuppression may slow **fibrotic progression**, it often fails to immediately or significantly reverse the **mechanical restriction** caused by established chest wall skin thickening.
- This approach neglects the physical aspect of **chest wall mobilization** required to improve the compliance of the thoracic cage.
*Lung-directed therapy only, as it contributes more to total compliance reduction*
- Measured **C_lung (50)** is indeed lower than **C_cw (75)**, but the total work of breathing is significantly impacted by the sum of these **resistances**.
- Ignoring the **chest wall component** limits the potential improvement in **vital capacity** and respiratory efficiency.
*Supportive care only, as both components contribute equally and irreversibly*
- Systemic sclerosis-related **pulmonary fibrosis** and **skin tightening** are not necessarily irreversible; early intervention can stabilize or improve lung function.
- This pessimistic view ignores that **C_cw** can be improved through **rehabilitation** and that **C_lung** can be managed with modern **immunosuppressive protocols**.
*Chest wall-directed physical therapy, as it is the primary limiting factor*
- This is incorrect as the **C_lung (50 mL/cm H₂O)** is actually more impaired than the **C_cw (75 mL/cm H₂O)**.
- Focusing solely on the chest wall ignores the **significant parenchymal disease** which is the more dominant factor in this patient's **restrictive physiology**.
Question 3: A 58-year-old man with end-stage pulmonary fibrosis is being evaluated for lung transplantation. His current static compliance is 25 mL/cm H2O (normal: 200 mL/cm H2O). He also has mild obesity (BMI 32) and ankylosing spondylitis affecting chest wall mobility. Post-transplant, assuming successful bilateral lung transplant with normal donor lungs, what would be the expected change in his total respiratory system compliance?
A. Return to completely normal respiratory compliance matching healthy individuals
B. Improved but still reduced compliance due to persistent chest wall restriction (Correct Answer)
C. Improved lung compliance but worsened chest wall compliance from surgery
D. Worse compliance initially due to transplant rejection and denervation
E. No significant change because the primary problem is muscular weakness
Explanation: ***Improved but still reduced compliance due to persistent chest wall restriction***
- Total respiratory system compliance is determined by the **inverse sum of lung and chest wall compliance** (1/Ct = 1/Cl + 1/Ccw).
- While the transplant provides **normal lung compliance**, the patient has extrinsic restrictions from **obesity** and **ankylosing spondylitis** that keep the chest wall compliance low.
*Return to completely normal respiratory compliance matching healthy individuals*
- Total compliance cannot return to normal because the **extrapulmonary constraints** (stiff chest wall and adipose tissue) are not altered by the surgery.
- The **ankylosing spondylitis** specifically limits the expansion of the thoracic cage, regardless of how healthy the new lungs are.
*Improved lung compliance but worsened chest wall compliance from surgery*
- While surgical trauma can cause temporary pain, a successful transplant doesn't inherently **permanently worsen** pre-existing chest wall stiffness.
- The primary physiological takeaway is the **net improvement** in one component (lungs) while the other remains a fixed restrictive limiting factor.
*Worse compliance initially due to transplant rejection and denervation*
- **Denervation** of the lung does not significantly decrease its static compliance; its elasticity is primarily due to its **structural parenchyma**.
- While **rejection** could decrease compliance, the question asks for the expected change assuming a **successful transplant** with normal donor tissue.
*No significant change because the primary problem is muscular weakness*
- The primary problem in this case is **structural restriction** (fibrosis and chest wall stiffening) rather than neuromuscular transmission or muscular weakness.
- Correcting end-stage **pulmonary fibrosis** will always provide a significant increase in total compliance, even if the result remains below the physiological norm.
Question 4: A research study compares two patients with different lung pathologies but identical functional residual capacity (FRC) of 3.0 L. Patient A has pulmonary fibrosis with FRC above the steep portion of the compliance curve. Patient B has emphysema with FRC on the flat upper portion of the curve. Both attempt to inhale the same tidal volume. Analyzing their work of breathing, which statement best characterizes the difference?
A. Patient A does more elastic work; Patient B does more resistive work
B. Patient B does more elastic work due to hyperinflation beyond optimal compliance (Correct Answer)
C. Patient B does less work because emphysematous lungs are more compliant
D. Patient A does less work because fibrotic lungs have increased elastic recoil assisting inspiration
E. Both do equal work because FRC and tidal volumes are identical
Explanation: ***Patient B does more elastic work due to hyperinflation beyond optimal compliance***
- Although **emphysema** creates high compliance at low volumes, the patient in this scenario is at a high **FRC** on the **flat upper portion** of the compliance curve where the lung is already overstretched.
- At this point, additional expansion requires significantly higher pressure changes for the same volume, drastically increasing the **elastic work of breathing** due to **hyperinflation** and loss of mechanical advantage.
*Patient A does more elastic work; Patient B does more resistive work*
- **Patient A** (fibrosis) does have high elastic work due to stiff lungs, but the question specifies **Patient B** is on the flat, non-compliant portion of the curve where elastic work becomes excessive.
- **Resistive work** is primarily associated with **airway obstruction** during expiration, while this specific comparison focuses on the **pressure-volume** (elastic) dynamics of inspiration.
*Patient B does less work because emphysematous lungs are more compliant*
- While **emphysematous lungs** have increased static compliance, they become functionally **non-compliant** at high lung volumes near total lung capacity (**TLC**).
- Operating on the **flat upper portion** of the curve means the lungs are near their limit of distensibility, requiring more effort, not less, to achieve a **tidal volume**.
*Patient A does less work because fibrotic lungs have increased elastic recoil assisting inspiration*
- In **pulmonary fibrosis**, increased **elastic recoil** actually opposes inspiration, making the lungs stiffer and requiring more work to expand.
- **Elastic recoil** assists expiration, not inspiration; therefore, **fibrotic lungs** always require significantly more work to inflate compared to healthy lungs.
*Both do equal work because FRC and tidal volumes are identical*
- Identical **FRC** and **tidal volumes** do not imply equal work if the patients are operating on different phases of the **pressure-volume curve**.
- The **work of breathing** is determined by the area under the pressure-volume loop, which is dictated by the **lung compliance** at that specific starting volume.
Question 5: A 32-year-old woman develops acute respiratory distress syndrome (ARDS) following sepsis. She is mechanically ventilated with tidal volume 450 mL and plateau pressure 35 cm H2O (PEEP 10 cm H2O). Her static compliance is calculated as 18 mL/cm H2O. The team considers changing ventilator settings. Analyzing her respiratory mechanics, what change would most effectively improve compliance while minimizing ventilator-induced lung injury?
A. Increase tidal volume to 600 mL to recruit more alveoli
B. Decrease PEEP to 5 cm H2O to reduce plateau pressure
C. Switch to pressure-control mode with same plateau pressure
D. Increase respiratory rate while maintaining current tidal volume
E. Increase PEEP to 15 cm H2O to prevent alveolar collapse (Correct Answer)
Explanation: ***Increase PEEP to 15 cm H2O to prevent alveolar collapse***
- In **ARDS**, static compliance is low due to widespread **alveolar collapse**; increasing **PEEP** (Positive End-Expiratory Pressure) recruits collapsed alveoli and shifts the lung to a more compliant part of the **pressure-volume curve**.
- Preventing cyclic collapse (atelectrauma) through adequate PEEP minimizes **Ventilator-Induced Lung Injury (VILI)** while effectively improving gas exchange area and lung mechanics.
*Increase tidal volume to 600 mL to recruit more alveoli*
- High tidal volumes increase the risk of **volutrauma** and **overdistension** of relatively healthy alveoli (the "baby lung" concept in ARDS).
- This action would likely increase the **plateau pressure** further above the 30 cm H2O safety threshold, worsening lung injury.
*Decrease PEEP to 5 cm H2O to reduce plateau pressure*
- Reducing PEEP below the **lower inflection point** leads to **atelectrauma** via the repeated opening and closing of unstable alveoli.
- While it might lower peak pressures, it would cause a drop in functional residual capacity and a significant decrease in **static compliance**.
*Switch to pressure-control mode with same plateau pressure*
- Simply switching to **pressure-control ventilation** does not inherently change the underlying **respiratory mechanics** or lung compliance if the plateau pressure remains constant.
- Without addressing alveolar recruitment through PEEP, the **compliance** remains compromised by the disease process itself.
*Increase respiratory rate while maintaining current tidal volume*
- Increasing the **respiratory rate** may help manage hypercapnia but does not directly improve the **static compliance** of the lung tissue.
- High rates can lead to **auto-PEEP** or intrinsic PEEP, which can complicate the assessment of plateau pressures and hemodynamics.
Question 6: A 55-year-old woman with idiopathic pulmonary fibrosis and a 40-year-old man with severe emphysema both have the same total lung capacity of 4.5 L on pulmonary function testing. However, their pressure-volume curves show opposite patterns. During inspiration from FRC, which patient requires greater change in pleural pressure to achieve the same tidal volume, and why?
A. The emphysema patient, because decreased elastic recoil requires more negative pressure to inflate
B. The fibrosis patient, because decreased compliance requires greater pressure change for the same volume (Correct Answer)
C. The fibrosis patient, because increased surface tension prevents alveolar expansion
D. The emphysema patient, because increased airway resistance requires more driving pressure
E. Both require the same pressure because they have equal total lung capacity
Explanation: ***The fibrosis patient, because decreased compliance requires greater pressure change for the same volume***
- **Pulmonary fibrosis** is a restrictive lung disease that increases the elastic recoil of the lung, which results in **decreased lung compliance**.
- Since compliance is defined as the change in volume over change in pressure (**C = ΔV/ΔP**), a patient with low compliance must generate a much more negative **pleural pressure** to achieve the same **tidal volume** as a healthy individual.
*The emphysema patient, because decreased elastic recoil requires more negative pressure to inflate*
- **Emphysema** involves the destruction of alveolar walls and elastic fibers, leading to **increased lung compliance** and "floppy" lungs.
- Due to this high compliance, the emphysema patient actually requires **less pressure change** to achieve a specific tidal volume compared to a healthy lung or a fibrotic lung.
*The fibrosis patient, because increased surface tension prevents alveolar expansion*
- While fibrosis makes expansion difficult, the primary mechanical defect is the stiffening of the **interstitial parenchyma** due to collagen deposition, not a change in **surfactant** or surface tension.
- **Surface tension** issues are more characteristic of conditions like infant respiratory distress syndrome (IRDS), which also reduces compliance but through a different mechanism.
*The emphysema patient, because increased airway resistance requires more driving pressure*
- While emphysema does involve increased **airway resistance** (especially during expiration due to airway collapse), the question asks about the **pressure-volume curve** mechanics related to lung expansion.
- Increased resistance affects the **work of breathing** related to gas flow, but compliance (the slope of the P-V curve) is the dominant factor determining the pressure required for volume change at a given state.
*Both require the same pressure because they have equal total lung capacity*
- **Total Lung Capacity (TLC)** is a static volume measurement and does not reflect the **dynamic work** or pressure required to inflate the lungs.
- Two patients can have the same lung volume but vastly different **compliance slopes**, meaning the stiff lung (fibrosis) will always require more pressure than the compliant lung (emphysema).
Question 7: A 70-year-old man with severe kyphoscoliosis presents with chronic dyspnea. Pulmonary function testing shows reduced total lung capacity and functional residual capacity. His lung tissue biopsy is normal, but respiratory muscle strength testing shows normal values. Analysis of his pressure-volume curve shows a normal curve for lung tissue alone, but decreased total respiratory system compliance. What explains his respiratory mechanics?
A. Primary decrease in chest wall compliance from skeletal deformity (Correct Answer)
B. Combined decrease in lung and chest wall compliance
C. Respiratory muscle weakness reducing lung volumes
D. Increased lung compliance with normal chest wall compliance
E. Primary decrease in lung compliance from parenchymal disease
Explanation: ***Primary decrease in chest wall compliance from skeletal deformity***
- **Kyphoscoliosis** acts as an extrapulmonary restrictive defect where the rigid skeletal deformity increases the "stiffness" of the thoracic cage, directly reducing **chest wall compliance**.
- The case specifies a **normal lung tissue pressure-volume curve**, confirming that the mechanical pathology originates exclusively from the **chest wall** rather than the lung parenchyma.
*Combined decrease in lung and chest wall compliance*
- While chronic kyphoscoliosis can eventually lead to secondary atelectasis, the biopsy and **pressure-volume curve** in this specific case confirm the lung tissue remains normal.
- A combined decrease would show abnormalities in the **lung-only** compliance curves, which is not present here.
*Respiratory muscle weakness reducing lung volumes*
- The patient's **respiratory muscle strength testing** shows normal values, which effectively rules out neuromuscular disorders or muscular fatigue.
- In muscle weakness, the compliance of the tissues might be normal, but the **maximal inspiratory and expiratory pressures** would be significantly reduced.
*Increased lung compliance with normal chest wall compliance*
- **Increased lung compliance** is a hallmark of obstructive diseases like **emphysema**, which results in increased, rather than decreased, lung volumes (TLC).
- Normal chest wall compliance would not occur in the presence of a severe physical deformity like **kyphoscoliosis**.
*Primary decrease in lung compliance from parenchymal disease*
- **Parenchymal diseases** such as interstitial fibrosis would show an abnormal lung biopsy and a shifted lung tissue **pressure-volume curve**.
- The scenario explicitly states the **lung tissue biopsy is normal**, pointing away from an intrinsic pulmonary cause for the restriction.
Question 8: A premature infant born at 28 weeks gestation develops respiratory distress syndrome. Arterial blood gas shows pH 7.25, PaCO2 55 mmHg, PaO2 50 mmHg on 60% FiO2. Chest X-ray reveals ground-glass opacities. Surfactant therapy is administered. Which mechanism best explains the improvement in lung mechanics following treatment?
A. Increased pulmonary blood flow improving V/Q matching
B. Decreased alveolar surface tension increasing compliance (Correct Answer)
C. Increased elastic recoil decreasing compliance
D. Bronchodilation decreasing airway resistance
E. Strengthened alveolar walls increasing elastic fibers
Explanation: ***Decreased alveolar surface tension increasing compliance***
- Surfactant contains **dipalmitoylphosphatidylcholine**, which breaks up the cohesive forces between water molecules at the air-fluid interface, effectively **decreasing surface tension**.
- By lowering surface tension, surfactant prevents **alveolar collapse** (atelectasis) and significantly **increases lung compliance**, making it easier for the lungs to inflate.
*Increased pulmonary blood flow improving V/Q matching*
- While surfactant indirectly improves **ventilation-perfusion (V/Q) matching** by opening collapsed alveoli, it is not the primary mechanical effect of the therapy.
- Pulmonary blood flow changes are secondary to improved **oxygenation** and decreased hypoxic pulmonary vasoconstriction rather than a direct mechanical action.
*Increased elastic recoil decreasing compliance*
- Increased **elastic recoil** actually makes the lungs stiffer and harder to expand, which would **decrease compliance** and worsen respiratory distress.
- Surfactant therapy aims to **decrease excessive recoil** caused by surface tension forces, thereby increasing the ease of lung expansion.
*Bronchodilation decreasing airway resistance*
- Surfactant acts specifically within the **alveoli** to maintain stability and does not have a direct physiological effect on **bronchial smooth muscle**.
- **Airway resistance** is primarily a function of the radius of the conducting airways, whereas RDS is a disease of alveolar **compliance**.
*Strengthened alveolar walls increasing elastic fibers*
- Surfactant is a **biochemical surface-active agent**, not a structural protein that reinforces the physical anatomy of the **alveolar walls**.
- The therapy provides immediate mechanical relief via surface tension reduction and does not involve the synthesis or modification of **elastic fibers**.
Question 9: A 45-year-old woman presents with progressive dyspnea and dry cough over 6 months. Chest CT shows bilateral interstitial infiltrates. Pulmonary function tests reveal FEV1/FVC ratio of 0.85, reduced total lung capacity, and a steep pressure-volume curve shifted downward and to the right. What is the primary mechanical change in her lungs?
A. Increased lung compliance with normal chest wall compliance
B. Increased lung and chest wall compliance
C. Decreased lung and increased chest wall compliance
D. Normal lung compliance with decreased chest wall compliance
E. Decreased lung compliance with normal chest wall compliance (Correct Answer)
Explanation: ***Decreased lung compliance with normal chest wall compliance***
- The patient presents with **Interstitial Lung Disease (ILD)**, where fibrosis results in stiff lungs that require greater pressure to inflate, signifying **decreased lung compliance**.
- The **FEV1/FVC ratio >0.7** and the **downward/right shift** of the pressure-volume curve are classic indicators of a **restrictive lung pattern** with high elastic recoil.
*Increased lung compliance with normal chest wall compliance*
- **Increased compliance** is characteristic of **emphysema**, where alveolar wall destruction leads to a loss of elastic recoil.
- In obstructive diseases like emphysema, the pressure-volume curve shifts **upward and to the left**, opposite to what is described here.
*Increased lung and chest wall compliance*
- This physiological state is not typically seen in clinical disease; most pathologies that affect compliance involve a **decrease** in flexibility.
- **Increased chest wall compliance** only occurs in specific scenarios like a **flail chest**, which does not present with chronic dry cough or interstitial infiltrates.
*Decreased lung and increased chest wall compliance*
- While **decreased lung compliance** fits the ILD profile, there is no clinical evidence in this case to suggest an abnormality in the **chest wall** structure.
- Diseases causing **restrictive patterns** usually affect either the lung parenchyma or the chest wall/neuromuscular system, but they do not typically increase chest wall flexibility.
*Normal lung compliance with decreased chest wall compliance*
- This pattern is seen in **extrapulmonary restrictive diseases** such as **obesity**, **kyphoscoliosis**, or **ankylosing spondylitis**.
- The presence of **bilateral interstitial infiltrates** on CT specifically points to intrinsic lung parenchyma pathology rather than a primary chest wall issue.
Question 10: A 65-year-old man with COPD undergoes pulmonary function testing. His FEV1 is 65% predicted, and spirometry shows an obstructive pattern. A pressure-volume loop demonstrates reduced elastic recoil with increased total lung capacity. When comparing his lungs to a healthy individual, what physiological change best explains his altered compliance?
A. Increased alveolar surface tension from surfactant deficiency
B. Destruction of elastic tissue in alveolar walls (Correct Answer)
C. Increased collagen deposition in interstitial spaces
D. Pulmonary vascular remodeling
E. Bronchial smooth muscle hypertrophy
Explanation: ***Destruction of elastic tissue in alveolar walls***
- In **emphysema**, a component of **COPD**, the destruction of **elastin** by proteases increases lung **compliance**, leading to a floppy, easily distensible lung.
- This loss of **elastic recoil** causes the pressure-volume loop to shift upward and to the left, resulting in **increased total lung capacity (TLC)** and air trapping.
*Increased alveolar surface tension from surfactant deficiency*
- **Surfactant deficiency** increases surface tension, which significantly **decreases lung compliance**, making the lungs difficult to inflate.
- This is a hallmark of **Neonatal Respiratory Distress Syndrome**, not the obstructive pattern seen in COPD patients.
*Increased collagen deposition in interstitial spaces*
- **Collagen deposition** is characteristic of **restrictive lung diseases** like pulmonary fibrosis, which leads to **decreased compliance**.
- This would result in a **reduced total lung capacity (TLC)** and a pressure-volume loop shifted downward and to the right.
*Pulmonary vascular remodeling*
- This refers to thickening of vessel walls and is associated with **pulmonary hypertension**, which primarily affects blood flow and pressures.
- While it can occur in late-stage COPD, it does not explain the primary change in **lung compliance** or the increase in TLC.
*Bronchial smooth muscle hypertrophy*
- This is a feature of **chronic bronchitis** and asthma that contributes to **airway resistance** and the obstructive FEV1/FVC ratio.
- While it limits airflow, it does not directly alter the **elasticity** of the lung parenchyma or the lung compliance seen on pressure-volume loops.
